Cargando…

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

BACKGROUND: Breast cancer exhibits significant molecular, pathological, and clinical heterogeneity. Current clinicopathological evaluation is imperfect for predicting outcome, which results in overtreatment for many patients, and for others, leads to death from recurrent disease. Therefore, addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saal, Lao H, Vallon-Christersson, Johan, Häkkinen, Jari, Hegardt, Cecilia, Grabau, Dorthe, Winter, Christof, Brueffer, Christian, Tang, Man-Hung Eric, Reuterswärd, Christel, Schulz, Ralph, Karlsson, Anna, Ehinger, Anna, Malina, Janne, Manjer, Jonas, Malmberg, Martin, Larsson, Christer, Rydén, Lisa, Loman, Niklas, Borg, Åke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341872/ https://www.ncbi.nlm.nih.gov/pubmed/25722745 http://dx.doi.org/10.1186/s13073-015-0131-9

Ejemplares similares

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
por: Brueffer, Christian, et al.
Publicado: (2018)

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
por: Brueffer, Christian, et al.
Publicado: (2020)

Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
por: Larsson, Christer, et al.
Publicado: (2020)

Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
por: Dahlgren, Malin, et al.
Publicado: (2021)

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
por: Vallon-Christersson, Johan, et al.
Publicado: (2019)

Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study
por: Staaf, Johan, et al.
Publicado: (2019)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
por: Glodzik, Dominik, et al.
Publicado: (2020)

Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative
por: Rydén, L., et al.
Publicado: (2018)

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

Refinement of breast cancer molecular classification by miRNA expression profiles
por: Søkilde, Rolf, et al.
Publicado: (2019)

Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
por: Demircan, Kamil, et al.
Publicado: (2023)

Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
por: Bengtsson, Ylva, et al.
Publicado: (2023)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
por: Staaf, Johan, et al.
Publicado: (2022)

Autoimmunity to selenoprotein P predicts breast cancer recurrence
por: Demircan, Kamil, et al.
Publicado: (2022)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
por: Olsson, Eleonor, et al.
Publicado: (2011)

Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
por: Demircan, Kamil, et al.
Publicado: (2021)

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
por: Winter, C., et al.
Publicado: (2016)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing
por: Alkner, Sara, et al.
Publicado: (2015)

Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing
por: Tang, Man-Hung Eric, et al.
Publicado: (2015)

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
por: Holm, Karolina, et al.
Publicado: (2010)

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2010)

Frequent miRNA-convergent fusion gene events in breast cancer
por: Persson, Helena, et al.
Publicado: (2017)

Regulatory networks and 5′ partner usage of miRNA host gene fusions in breast cancer
por: Hafstað, Völundur, et al.
Publicado: (2022)

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data
por: Saal, Lao H, et al.
Publicado: (2002)

BASE - 2nd generation software for microarray data management and analysis
por: Vallon-Christersson, Johan, et al.
Publicado: (2009)

Molecular characteristics of inherited breast tumors
por: Borg, Å, et al.
Publicado: (2000)

Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
por: Dalal, Hina, et al.
Publicado: (2022)

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
por: Romero, Quinci, et al.
Publicado: (2011)

TopHat-Recondition: a post-processor for TopHat unmapped reads
por: Brueffer, Christian, et al.
Publicado: (2016)

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
por: Olsson, Eleonor, et al.
Publicado: (2015)

Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

The HER2-Encoded miR-4728-3p Regulates ESR1 through a Non-Canonical Internal Seed Interaction
por: Newie, Inga, et al.
Publicado: (2014)

StickWRLD as an Interactive Visual Pre-Filter for Canceromics-Centric Expression Quantitative Trait Locus Data
por: Rumpf, Robert Wolfgang, et al.
Publicado: (2014)

The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology
por: Dihge, Looket, et al.
Publicado: (2016)

Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor
por: Narbe, Ulrik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hboec4f77e9p3bmi8t8c59212j